Physician
Jagannath S. Surpure, M.D.P.C.
Jagannath S. Surpure, M.D.P.C. was paid $2.61M by Medicaid between Jan 2018 and Dec 2024, across 51 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 28% of everything it billed.
33Billing provider infoJAGANNATH S. SURPURE, M.D.P.C.
HENDERSON, NV 89014
HENDERSON, NV 89014
33aNPI1750422481assigned 02/08/2007
33bProvider typePediatrics Physician
28Total paid$2.61M
24GClaims62,170
24DCodes billed51
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Nevada
Rank by total paid#19 of 267
Median peer was paid$116K
This provider vs. median22×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 769 | $29K | |
| 2019 | 13,899 | $606K | |
| 2020 | 7,292 | $295K | |
| 2021 | 12,023 | $419K | |
| 2022 | 13,133 | $547K | |
| 2023 | 9,079 | $398K | |
| 2024incomplete | 5,975 | $310K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 28% | 10,562 | 9,668 | $717K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 12,019 | 11,212 | $633K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 8.7% | 2,882 | 2,774 | $227K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 8.6% | 2,176 | 2,056 | $225K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 8.3% | 5,386 | 5,080 | $216K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.1% | 1,805 | 1,727 | $133K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4.9% | 1,696 | 1,631 | $128K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.5% | 1,101 | 1,064 | $91K |
| 99401 | 3.5% | 3,346 | 3,252 | $91K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.4% | 459 | 423 | $36K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,630 | 1,281 | $24K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 87 | 40 | $16K |
39 more codes
| 94760 | <1% | 10,120 | $15K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,675 | $15K |
| 99383 | <1% | 124 | $9K | |
| 76140 | <1% | 165 | $8K | |
| 99050 | <1% | 426 | $6K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 258 | $5K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 109 | $3K |
| 99384 | <1% | 34 | $3K | |
| 99382 | <1% | 14 | $1K | |
| 90671 | <1% | 58 | $671.36 | |
| 87807 | <1% | 100 | $555.29 | |
| 87428 | <1% | 29 | $453.11 | |
| 81002 | <1% | 173 | $282.64 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 16 | $253.51 |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 14 | $227.59 |
| 94664 | <1% | 16 | $169.73 | |
| 99177 | <1% | 22 | $57.42 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 110 | $37.50 |
| 90686 | <1% | 536 | $15.15 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 16 | $11.95 |
| 99174 | <1% | 19 | $10.02 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 16 | $4.20 |
| 99072 | 0% | 1,243 | $0.00 | |
| 90633 | 0% | 430 | $0.00 | |
| 90715 | 0% | 180 | $0.00 | |
| 90710 | 0% | 450 | $0.00 | |
| 90700 | 0% | 67 | $0.00 | |
| 90670 | 0% | 627 | $0.00 | |
| 99173 | 0% | 157 | $0.00 | |
| 90734 | 0% | 22 | $0.00 | |
| 90619 | 0% | 131 | $0.00 | |
| 90696 | 0% | 74 | $0.00 | |
| 90716 | 0% | 12 | $0.00 | |
| 90647 | 0% | 106 | $0.00 | |
| 90651 | 0% | 155 | $0.00 | |
| 90698 | 0% | 14 | $0.00 | |
| 90680 | 0% | 32 | $0.00 | |
| 90733 | 0% | 206 | $0.00 | |
| 90723 | 0% | 65 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSURPURE, JAGANNATH (MEDICAL DIRECTOR)